Amy S. Paller on Muck Rack

Amy S. Paller

Chicago
As seen in: Nature, WebMD, Wiley Online Library, American Journal of Clinical Dermatology, BMJ Open, JAMA (The Journal of the American Medical Association), JAMA Dermatology, Medscape, American Medical Association (AMA), The Lancet and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Amy S.

Contact Amy S., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Highlights in Atopic Dermatitis From AAD 2026

|
By Amy S. Paller
| Medscape Verified
This content was developed independently and is not endorsed by the American Academy of Dermatology. Highlights in atopic dermatitis (AD) from the 2026 American Academy of Dermatology annual meeting included long-term safety of upadacitinib in moderate-to-severe AD, promising results for the monoclonal antibody amlitelimab, and robust outcomes for dupilumab in adolescents, as reported by Dr Amy S. Paller of Northwestern University in Chicago.
Open in Who Shared Issue with article?

Tape strips capture immune and epidermal hyperplasia markers in the major orphan ichthyoses

|
By Amy S. Paller, Emma Guttman-Yassky
| jidonline.org
Keywords ichthyosis Netherton syndrome congenital ichthyosis erythroderma lamellar ichthyosis epidermolytic ichthyosis Abbreviations CE (cornified envelope) CIE (congenital ichthyosiform erythroderma) DEG (differentially expressed gene) EDC (epidermal differentiation complex) EI (epidermolytic ichthyosis) FDR (false discovery rate) FCH (fold change) IASI (Ichthyosis Area and Severity Index) KEGG (Kyoto Encyclopedia of Genes and Genomes) LI (lamellar ichthyosis) LS (lesional) MSiGDb (Molecular...
Open in Who Shared Issue with article?

Research Portal of the TU Dresden

|
By Amy S. Paller, Andreas Pinter, Lara Lee
| tu-dresden.de
BACKGROUND: Infants and young children with severe atopic dermatitis (AD) have a high burden of disease with a strong impact on quality of life. Here we assess long-term efficacy and safety of dupilumab in pediatric patients aged 6 months to 5 years with severe AD.
Open in Who Shared Issue with article?
See all 108 licensed articles (117 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified